Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare personnel.

Maria Elena Romero-IbarguengoitiaDiego Rivera-SalinasYodira Guadalupe Hernández-RuízAna Gabriela Armendariz-VázquezArnulfo González-CantúIrene Antonieta Barco-FloresRosalinda González-FacioLaura Patricia Montelongo-CruzGerardo Francisco Del Rio-ParraMauricio René Garza-HerreraJessica Andrea Leal-MeléndezMiguel Ángel Sanz-Sánchez

Published in: PloS one (2022)

The third dose applied six months after the original BNT162b2 regimen increased the quantitative SARS-CoV-2 spike 1-2 IgG antibody titers. The booster dose was well tolerated and caused no severe AEFI.

Keyphrases

sars cov
healthcare
respiratory syndrome coronavirus
high resolution
early onset
mass spectrometry
social media